Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongqi Xue

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Clinical and Translational Science|July 8, 2024
A phase I thorough QT/QTc study evaluating therapeutic and supratherapeutic doses of avacopan in healthy participantsShichang Miao, Peter Staehr, Ezra Tai, et al.
British Journal of Clinical Pharmacology|September 23, 2024
Concentration-QTc analysis of soticlestat in healthy adults: An alternative to a thorough QT studyWei Yin, Nobuhito Dote, Hiroyuki Fukase, et al.
Clinical Pharmacology in Drug Development|July 29, 2023
Concentration-QTc Relationship from a Single Ascending Dose Study of ANAVEX3-71, a Novel Sigma-1 Receptor and Allosteric M1 Muscarinic Receptor Agonist in Development for the Treatment of Frontotemporal Dementia, Schizophrenia, and Alzheimer's DiseaseEmmanuel O Fadiran, Edward Hammond, James Tran, et al.
Clinical Pharmacology in Drug Development|January 29, 2024
Concentration-QTcF Modeling of Icenticaftor from a Randomized, Placebo- and Positive-Controlled Thorough QT Study in Healthy ParticipantsGanesh R Iyer, Borje Darpo, Hongqi Xue, et al.
Clinical Pharmacology in Drug Development|September 13, 2022
Evaluation of Deutetrabenazine's Potential to Delay Cardiac Repolarization Using Concentration-QTc AnalysisFrank Schneider, Borje Darpo, Pippa S Loupe, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 1, 2020
Combination of olanzapine and samidorphan has no clinically relevant effects on ECG parameters, including the QTc interval: Results from a phase 1 QT/QTc studyLei Sun, Sergey Yagoda, Hongqi Xue, et al.
Clinical Pharmacology in Drug Development|December 11, 2019
Evaluation of Clinical Cardiac Safety of Itacitinib, a JAK1 Inhibitor, in Healthy ParticipantsXiaohua Gong, Borje Darpo, Hongqi Xue, et al.
Clinical and Translational Science|March 8, 2020
No QTc Prolongation With Zanubrutinib: Results of Concentration-QTc Analysis From a Thorough QT Study in Healthy SubjectsSong Mu, Borje Darpo, Zhiyu Tang, et al.
Clinical and Translational Science|March 23, 2023
A randomized, single-dose, crossover study of the effects of ulotaront on electrocardiogram intervals in subjects with schizophreniaHironobu Tsukada, Snezana M Milanovic, Borje Darpo, et al.
Clinical and Translational Science|March 18, 2022
A thorough QTc study to evaluate the effects of oral rilzabrutinib administered alone and with ritonavir in healthy subjectsSibel Ucpinar, Borje Darpo, Ann Neale, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Clinical and Translational Science|July 8, 2024
A phase I thorough QT/QTc study evaluating therapeutic and supratherapeutic doses of avacopan in healthy participantsShichang Miao, Peter Staehr, Ezra Tai, et al.
British Journal of Clinical Pharmacology|September 23, 2024
Concentration-QTc analysis of soticlestat in healthy adults: An alternative to a thorough QT studyWei Yin, Nobuhito Dote, Hiroyuki Fukase, et al.
Clinical Pharmacology in Drug Development|July 29, 2023
Concentration-QTc Relationship from a Single Ascending Dose Study of ANAVEX3-71, a Novel Sigma-1 Receptor and Allosteric M1 Muscarinic Receptor Agonist in Development for the Treatment of Frontotemporal Dementia, Schizophrenia, and Alzheimer's DiseaseEmmanuel O Fadiran, Edward Hammond, James Tran, et al.
Clinical Pharmacology in Drug Development|January 29, 2024
Concentration-QTcF Modeling of Icenticaftor from a Randomized, Placebo- and Positive-Controlled Thorough QT Study in Healthy ParticipantsGanesh R Iyer, Borje Darpo, Hongqi Xue, et al.
Clinical Pharmacology in Drug Development|September 13, 2022
Evaluation of Deutetrabenazine's Potential to Delay Cardiac Repolarization Using Concentration-QTc AnalysisFrank Schneider, Borje Darpo, Pippa S Loupe, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 1, 2020
Combination of olanzapine and samidorphan has no clinically relevant effects on ECG parameters, including the QTc interval: Results from a phase 1 QT/QTc studyLei Sun, Sergey Yagoda, Hongqi Xue, et al.
Clinical Pharmacology in Drug Development|December 11, 2019
Evaluation of Clinical Cardiac Safety of Itacitinib, a JAK1 Inhibitor, in Healthy ParticipantsXiaohua Gong, Borje Darpo, Hongqi Xue, et al.
Clinical and Translational Science|March 8, 2020
No QTc Prolongation With Zanubrutinib: Results of Concentration-QTc Analysis From a Thorough QT Study in Healthy SubjectsSong Mu, Borje Darpo, Zhiyu Tang, et al.
Clinical and Translational Science|March 23, 2023
A randomized, single-dose, crossover study of the effects of ulotaront on electrocardiogram intervals in subjects with schizophreniaHironobu Tsukada, Snezana M Milanovic, Borje Darpo, et al.
Clinical and Translational Science|March 18, 2022
A thorough QTc study to evaluate the effects of oral rilzabrutinib administered alone and with ritonavir in healthy subjectsSibel Ucpinar, Borje Darpo, Ann Neale, et al.
Pageof 5